SD Biosensor, Inc. (KRX:137310)

South Korea · Delayed Price · Currency is KRW

6,540.00

-250.00 (-3.68%)

Last updated: Aug 12, 2026, 2:52 PM KST

SD Biosensor Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	718,784	710,581	694,574	655,677	2,932,001	2,929,961
Revenue Growth	2.17%	2.31%	5.93%	-77.64%	0.07%	73.77%
Gross Profit	328,283	321,449	336,971	122,449	1,390,110	1,593,176
Operating Income	-81,806	-82,853	-54,471	-248,085	1,146,624	1,387,733
Net Income	-470,727	-512,106	-98,411	-467,712	911,362	1,088,471
Earnings Per Share	-3934.15	-4279.19	-805.00	-4219.00	8996.76	11161.00
EPS Growth	-	-	-	-	-19.39%	69.54%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	497,602	774,175	467,750	557,717	2,069,971	1,895,499
Total Debt	313,627	673,040	610,862	608,476	30,694	195,668
Net Cash (Debt)	183,975	101,135	-143,112	-50,759	2,039,277	1,699,830
Net Cash Growth	-	-	-	-	19.97%	306.25%
Net Cash Per Share	1537.59	845.09	-1170.66	-457.86	20131.28	17430.38

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	370,083	357,516	156,527	-242,319	889,008	1,234,945
Capital Expenditures	-54,636	-57,086	-78,783	-142,566	-301,999	-190,053
Free Cash Flow	315,447	300,431	77,744	-384,884	587,008	1,044,892
Free Cash Flow Growth	434.93%	286.44%	-	-	-43.82%	137.22%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	45.67%	45.24%	48.52%	18.68%	47.41%	54.37%
Operating Margin	-11.38%	-11.66%	-7.84%	-37.84%	39.11%	47.36%
Pretax Margin	-121.78%	-129.21%	-31.56%	-66.89%	42.36%	49.98%
Profit Margin	-65.49%	-72.07%	-14.17%	-71.33%	31.08%	37.15%
FCF Margin	43.89%	42.28%	11.19%	-58.70%	20.02%	35.66%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	3.37	5.27
Forward PE	-	13.43	13.43	13.43	4.73	5.53
P/FCF Ratio	2.47	3.54	16.18	-	5.24	5.49
PS Ratio	1.08	1.50	1.81	2.13	1.05	1.96